Skip to main content

Table 2 Sensitivity analysis of all studies based on study quality and status of the country where the study was conducted

From: A systematic review and meta-analysis of gender difference in epidemiology of HIV, hepatitis B, and hepatitis C infections in people with severe mental illness

Subgroups

Studies, n

Prevalence (%)

95% CI

Type of infectious disease

Gender

Heterogeneity between groups (P value)

Country

     

0.989

 Developed

15

7.47

3.79–14.28

HIV

Both

 

 Developing

10

7.52

3.75–14.51

HIV

Both

 

Country

     

0.710

 Developed

8

7.72

3.09–18.02

HIV

Men

 

 Developing

5

6.13

2.73–13.20

HIV

Men

 

Country

     

0.660

 Developed

7

7.11

242–19.09

HIV

Women

 

 Developing

5

9.63

2.73–22.70

HIV

Women

 

Quality of studies

     

0.058

 High

14

5.21

2.87–9.28

HIV

Both

 

 Moderate and poor

11

12.13

6.29–22.10

HIV

Both

 

Quality of studies

     

0.352

 High

7

6.43

2.96–13.39

HIV

Women

 

 Moderate and poor

5

12.03

3.95–31.24

HIV

Women

 

Quality of studies

     

0.059

 High

7

4.42

2.19–8.72

HIV

Men

 

 Moderate and poor

6

11.99

3.95–31.24

HIV

Men

 

Country

     

0.059

 Developed

3

19.37

8.84–37.32

HBV

Both

 

 Developing

1

7.53

4.03–13.62

HBV

Both

 

Country

     

0.167

 Developed

3

23.19

7.17–54.14

HBV

Men

 

 Developing

1

9.43

5.15–16.65

HBV

Men

 

Country

     

0.172

 Developed

3

15.66

3.79–46.68

HBV

Women

 

 Developing

1

4.88

1.84–12.29

HBV

Women

 

Quality of studies

     

0.370

 High

1

10.75

5.62–19.60

HBV

Both

 

 Moderate and poor

3

17.38

7.22–36.26

HBV

Both

 

Quality of studies

     

0.609

 High

1

14.38

10.84–18.83

HBV

Men

 

 Moderate and poor

3

20.57

4.85–56.80

HBV

Men

 

Quality of studies

     

0.458

 High

1

7.55

4.67–11.96

HBV

Women

 

 Moderate and poor

3

13.97

2.76–48.17

HBV

Women

 

Country

     

0.182

 Developed

4

6.21

3.56–10.62

HCV

Both

 

 Developing

1

12.10

5.29–25.35

HCV

Both

 

Country

     

0.031

 Developed

4

7.61

3.46–15.94

HCV

Men

 

 Developing

1

17.58

14.52–21.12

HCV

Men

 

Country

     

0.352

 Developed

4

4.65

1.65–12.41

HCV

Women

 

 Developing

1

7.82

5.04–11.93

HCV

Women

 

Quality of studies

     

0.135

 High

4

6.46

3.75–10.88

HCV

Both

 

 Poor

1

10.99

6.93–17.00

HCV

Both

 

Quality of studies

     

0.940

 High

4

9.20

4.33–18.49

HCV

Men

 

 Poor

1

8.89

5.12–15.00

HCV

Men

 

Quality of studies

     

0.017

 High

1

4.17

1.80–9.37

HCV

Women

 

 Poor

3

14.08

7.75–24.24

HBV

Women

 
  1. HIV human immunodeficiency virus infection, HBV hepatitis B virus, HCV hepatitis C virus